GTC Biotherapeutics (fka GTCB)

[croumagnon]

"Agree the revere split seems unlikely"

At this point, the reverse split has become irrelevant because it will not help the finances of GTCB and, as far as delisting is concerned, they do not have to do it until about February. By February, this company will either be dead, would have been bought out, or be doing so well that the $1 threshold for the price would become a non-issue...